The Hemolytic Anemia Sales Specialist is responsible for driving awareness and adoption of Pyrukynd and Aqvesme by building relationships with HCPs and managing territory-level sales goals. They will collaborate with cross-functional teams to ensure seamless patient support and execute strategic business plans to meet revenue objectives.
The Associate Director will lead the development and execution of value, access, and pricing strategies for the Agios portfolio in Europe and the GCC. This role involves collaborating with internal teams and external distributors to secure patient access through effective negotiations and value-based storytelling.
Lead forecasting and national performance analytics for marketed and pipeline portfolios, focusing on rare and genetically defined diseases. Build demand and revenue models to anchor executive planning and maintain KPI dashboards to track product performance.
Lead market research and competitive intelligence functions to inform brand and portfolio strategy for rare and genetically defined diseases. Translate external signals and competitor activity into actionable insights for cross-functional leadership and commercial teams.
The AD, Field Access Manager ensures patient access to therapies by navigating payer coverage and specialty pharmacy pathways. They serve as a regional expert to remove access barriers through collaboration with HCPs, payers, and internal teams.
The Associate Director will engage with Key Opinion Leaders and Centers of Excellence in classical hematology to gather market insights. They will serve as the primary liaison between marketing initiatives and KOLs to shape brand strategy.
The MSL will manage key opinion leader development and scientific exchange within the rare disease therapeutic areas of hemolytic anemias and myelodysplastic syndrome. They will also support clinical trial recruitment, facilitate investigator-sponsored studies, and provide medical insights to internal teams.
